Icon (ICLR) Free Cash Flow (2009 - 2026)
Icon's (ICLR) quarterly Free Cash Flow came in at $323.7 million in Q2 2026, up 81.36% year-over-year from $178.5 million in Q2 2025, and up 63.67% quarter-over-quarter from $197.8 million in Q1 2026.
Analysis
Icon (ICLR) Free Cash Flow (2009 - 2026) Analysis & Trends
Icon (ICLR) has reported Free Cash Flow for 18 consecutive years, with $323.7 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Free Cash Flow rose 81.36% year-over-year to $323.7 million in Q2 2026; TTM through Jun 2026 was $1.6 billion, a 2.21% decrease from a year earlier, with the FY2025 full-year figure at $1.5 billion, down 12.46% from the prior year.
- Free Cash Flow was $323.7 million for Q2 2026 at Icon, up from $197.8 million in the prior quarter.
- Over five years, Free Cash Flow peaked at $664.8 million in Q4 2024 and troughed at -$2.4 million in Q4 2022.
- A 5-year average of $319.7 million and a median of $276.0 million in 2024 frame the typical range for Free Cash Flow.
- Across the five-year window, Free Cash Flow tumbled 100.71% in 2022 and jumped 20541.44% in 2023, its largest moves.
- Over 5 years, Free Cash Flow stood at -$2.4 million in 2022, then jumped by 20541.44% to $492.8 million in 2023, then soared by 34.89% to $664.8 million in 2024, then dropped by 11.46% to $588.6 million in 2025, then slumped by 45.01% to $323.7 million in 2026.
- The last three Free Cash Flow figures came in at $323.7 million (Q2 2026), $197.8 million (Q1 2026), and $588.6 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 360.00 Mn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 138.10 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 323.69 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 148.62 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | 19.90 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | -46.89 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | -617,000.00 |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | -2.84 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | -3.24 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 323.69 Mn |
| Mar 31, 2026 | 197.78 Mn |
| Dec 31, 2025 | 588.63 Mn |
| Sep 30, 2025 | 441.30 Mn |
| Jun 30, 2025 | 178.48 Mn |
| Mar 31, 2025 | 297.15 Mn |
| Dec 31, 2024 | 664.81 Mn |
| Sep 30, 2024 | 446.01 Mn |
| Jun 30, 2024 | 254.88 Mn |
| Mar 31, 2024 | 354.23 Mn |
| Dec 31, 2023 | 492.84 Mn |
| Sep 30, 2023 | 370.62 Mn |
| Jun 30, 2023 | 236.02 Mn |
| Mar 31, 2023 | 202.24 Mn |
| Dec 31, 2022 | -2.41 Mn |
| Sep 30, 2022 | 251.08 Mn |
| Jun 30, 2022 | 210.26 Mn |
| Mar 31, 2022 | 246.55 Mn |
| Dec 31, 2021 | 337.50 Mn |
| Sep 30, 2021 | 323.38 Mn |